380 related articles for article (PubMed ID: 29270746)
1. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
[TBL] [Abstract][Full Text] [Related]
2. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
[TBL] [Abstract][Full Text] [Related]
3. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases.
Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644
[TBL] [Abstract][Full Text] [Related]
5. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.
Cai X; Zhai J; Kaplan DE; Zhang Y; Zhou L; Chen X; Qian G; Zhao Q; Li Y; Gao L; Cong W; Zhu M; Yan Z; Shi L; Wu D; Wei L; Shen F; Wu M
Hepatology; 2012 Nov; 56(5):1804-16. PubMed ID: 22684921
[TBL] [Abstract][Full Text] [Related]
6. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.
Komuta M; Spee B; Vander Borght S; De Vos R; Verslype C; Aerts R; Yano H; Suzuki T; Matsuda M; Fujii H; Desmet VJ; Kojiro M; Roskams T
Hepatology; 2008 May; 47(5):1544-56. PubMed ID: 18393293
[TBL] [Abstract][Full Text] [Related]
8. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT
World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CD133+ parenchymal cells in the liver: histology and culture.
Yoshikawa S; Zen Y; Fujii T; Sato Y; Ohta T; Aoyagi Y; Nakanuma Y
World J Gastroenterol; 2009 Oct; 15(39):4896-906. PubMed ID: 19842219
[TBL] [Abstract][Full Text] [Related]
10. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Lee WS; Lee KW; Heo JS; Kim SJ; Choi SH; Kim YI; Joh JW
Surg Today; 2006; 36(10):892-7. PubMed ID: 16998683
[TBL] [Abstract][Full Text] [Related]
11. Combined hepatocellular-cholangiocarcinoma with stem cell features, ductal plate malformation subtype: a case report and proposal of a new subtype.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):737-48. PubMed ID: 23573322
[TBL] [Abstract][Full Text] [Related]
12. The Prognostic Value of Cytokeratin and Sal-Like Protein 4 Expression in Hepatocellular Carcinoma and Intra-Hepatic Cholangiocarcinoma in Taiwan.
Lai YS; Cheng CC; Lee MT; Chao WT; Lai YC; Hsu YH; Liu YH
Int J Med Sci; 2018; 15(14):1746-1756. PubMed ID: 30588199
[No Abstract] [Full Text] [Related]
13. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
Xu J; Zhang C; Qiao A; Xi Y
Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
[TBL] [Abstract][Full Text] [Related]
14. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
[TBL] [Abstract][Full Text] [Related]
15. Combined hepatocellular and cholangiocarcinoma with marked squamous cell carcinoma components arising in non-cirrhotic liver.
Tsuneyama K; Kaizaki Y; Doden K; Kidani E; Harada K; Sasaki M; Nakanuma Y
Pathol Int; 2003 Feb; 53(2):90-7. PubMed ID: 12588436
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic features of combined hepatic carcinoma].
He C; Yin HF; Liu P; Zhang Y; Zhang JB
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):824-8. PubMed ID: 24507101
[TBL] [Abstract][Full Text] [Related]
17. Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2017 Feb; 70(3):423-434. PubMed ID: 27634656
[TBL] [Abstract][Full Text] [Related]
18. Liver stem cells: implications for hepatocarcinogenesis.
Alison MR
Stem Cell Rev; 2005; 1(3):253-60. PubMed ID: 17142862
[TBL] [Abstract][Full Text] [Related]
19. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers.
Lee CH; Hsieh SY; Chang CJ; Lin YJ
J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166
[TBL] [Abstract][Full Text] [Related]
20. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
[No Abstract] [Full Text] [Related]
[Next] [New Search]